SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007359
Filing Date
2022-05-05
Accepted
2022-05-05 16:07:02
Documents
92
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20220331x10q.htm   iXBRL 10-Q 1572990
2 EX-31.1 irwd-20220331xex31d1.htm EX-31.1 16575
3 EX-31.2 irwd-20220331xex31d2.htm EX-31.2 16634
4 EX-32.1 irwd-20220331xex32d1.htm EX-32.1 7973
5 EX-32.2 irwd-20220331xex32d2.htm EX-32.2 7937
  Complete submission text file 0001558370-22-007359.txt   8242101

Data Files

Seq Description Document Type Size
6 EX-101.SCH irwd-20220331.xsd EX-101.SCH 66611
7 EX-101.CAL irwd-20220331_cal.xml EX-101.CAL 68055
8 EX-101.DEF irwd-20220331_def.xml EX-101.DEF 315954
9 EX-101.LAB irwd-20220331_lab.xml EX-101.LAB 510564
10 EX-101.PRE irwd-20220331_pre.xml EX-101.PRE 495782
86 EXTRACTED XBRL INSTANCE DOCUMENT irwd-20220331x10q_htm.xml XML 1468044
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 22896207
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences